Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | completed | Phase 3 | 111 | Seoul National University HospitalOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT02581462 | FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer(PETRARCA) | completed | Phase 2 / Phase 3 | 81 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER |
| 1 |
| Aug 11, 2020 |
| clinicaltrials |
| NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | completed | Phase 3 | 8 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT04351867 | A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer | unknown | Phase 3 | 196 | LiNingOTHER_GOV | 1 | Jul 16, 2020 | clinicaltrials |
| NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma(GAMMA-1) | completed | Phase 3 | 432 | Gilead SciencesINDUSTRY | 16 | May 26, 2020 | clinicaltrials |
| NCT03160924 | The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy | unknown | Phase 3 | 50 | Chinese University of Hong KongOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | completed | Phase 3 | 546 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 7, 2020 | clinicaltrials |
| NCT03817268 | Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection(CAPOGA) | unknown | Phase 3 | 768 | The First Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT01761461 | Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial(ARTIST-II) | unknown | Phase 3 | 547 | Samsung Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT04135781 | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | unknown | Phase 3 | 616 | Zhejiang Cancer HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT03264807 | Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer | unknown | Phase 3 | 518 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 3, 2020 | clinicaltrials |
| NCT01516944 | Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 749 | Hebei Medical UniversityOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT01248403 | A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy(AIO-STO-0111) | completed | Phase 3 | 300 | Krankenhaus NordwestOTHER | 1 | Jan 29, 2020 | clinicaltrials |
| NCT00296322 | Trial of Adjuvant Chemotherapy for Gastric Cancer | completed | Phase 3 | 528 | Asan Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00915382 | Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS | completed | Phase 3 | 625 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01470742 | Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | completed | Phase 3 | 15 | National Cancer Institute (NCI)NIH | 1 | Nov 13, 2019 | clinicaltrials |
| NCT03788226 | A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer | unknown | Phase 3 | 600 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 16, 2019 | clinicaltrials |
| NCT02076594 | Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer | terminated | Phase 3 | 171 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma | completed | Phase 3 | 355 | Eli Lilly and CompanyINDUSTRY | 30 | Sep 25, 2019 | clinicaltrials |
| NCT01170663 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma(RAINBOW) | completed | Phase 3 | 665 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 18, 2019 | clinicaltrials |
| NCT03023436 | Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis | unknown | Phase 3 | 220 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Sep 13, 2019 | clinicaltrials |
| NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 716 | Krankenhaus NordwestOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT03941561 | S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） | recruiting | Phase 3 | 1,006 | Fudan UniversityOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03961373 | Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer(Neo-D2plus) | recruiting | Phase 3 | 539 | University of SienaOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT02736552 | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT03654534 | Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy | unknown | Phase 3 | 374 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03889626 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | unknown | Phase 3 | 242 | Fudan UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT02647476 | Postoperative Enteral Immunonutrition in Gastric Cancer | completed | Phase 3 | 98 | Jagiellonian UniversityOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02490111 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | completed | Phase 3 | 521 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 1 | Feb 8, 2019 | clinicaltrials |
| NCT03350477 | Bioinformation Therapy for Gastric Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT01824459 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | completed | Phase 3 | 576 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02120885 | An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial(Gastric cancer) | completed | Phase 3 | 70 | Yonsei UniversityOTHER | 1 | Jan 22, 2019 | clinicaltrials |
| NCT01065688 | A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer | completed | Phase 3 | 120 | Wakayama Medical UniversityOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT03680261 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | unknown | Phase 3 | 556 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03598348 | Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer | unknown | Phase 3 | 288 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03601988 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | unknown | Phase 3 | 408 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT02706184 | E. Coli Nissle in Oncology(EcNO) | completed | Phase 3 | 20 | University of HohenheimOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT02150447 | The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding | terminated | Phase 3 | 394 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 4, 2018 | clinicaltrials |
| NCT01813253 | Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer | terminated | Phase 3 | 400 | Kuhnil Pharmaceutical Co., Ltd.INDUSTRY | 3 | Mar 26, 2018 | clinicaltrials |
| NCT03475615 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | unknown | Phase 3 | 215 | Fudan UniversityOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT01683864 | Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer(HIPECStomach) | terminated | Phase 2 / Phase 3 | 3 | University Hospital TuebingenOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT02110628 | Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy(WCGCC-1202) | unknown | Phase 3 | 588 | West China HospitalOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT03399253 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | unknown | Phase 2 / Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT02461407 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | unknown | Phase 2 / Phase 3 | 378 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT03355612 | XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma | unknown | Phase 3 | 456 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 28, 2017 | clinicaltrials |
| NCT02356276 | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2(EHTLAGCRGD2) | unknown | Phase 3 | 584 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT00407186 | Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) | unknown | Phase 3 | 788 | Dutch Colorectal Cancer GroupOTHER | 1 | Oct 10, 2017 | clinicaltrials |
| NCT02509806 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 23, 2020source: clinicaltrials